Lonza

February 4, 2019

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

[vc_row][vc_column][vc_column_text] Cell and gene therapies (CGTs) offer an unprecedented opportunity to treat diseases for which existing interventions are inadequate, potentially offering cures for previously terminal illnesses. […]
September 12, 2018

The Future of BioManufacturing: Automated Closed Systems for Cell & Gene Therapy Processes

June 4, 2018

The Future of BioManufacturing: In Silico Modelling

April 12, 2018
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

[vc_row][vc_column][vc_column_text] Swiss CDMO Lonza recently opened the world’s biggest manufacturing plant to produce custom viruses for use in cell and gene therapies. The facility, based in […]
January 23, 2018
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?

[vc_row][vc_column][vc_column_text]The Food and Drug Administration recently announced the first ever approval of a directly administered gene therapy in the United States. Spark Therapeutics one-time gene therapy […]
September 26, 2017

The Future of BioManufacturing: Cell Line Engineering

June 14, 2017

The Future of BioManufacturing: Modular Factories & End-to-End Solutions

May 23, 2017
Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

[vc_row][vc_column][vc_column_text] Dutch Contract Development & Manufacturing Organisation Patheon has been acquired by Thermo Fisher Scientific in a $7.2B deal. The acquisition, which includes the assumption of […]
May 10, 2017

The Future of BioManufacturing: Disposable Single-Use Technologies

Contact Us